Bruker Corporation (Nasdaq: BRKR) today announces the launch of the new X4 POSEIDON™, a high-performance 3D X-ray microscope (XRM) using micro-Computed Tomography (microCT). This innovative ...

Similar improvements are observed in immunopeptidomics. Bruker expects to launch the new AIP on the timsTOF Ultra 2 system at ASMS 2025 with timsTOF Ultra 2 field upgradability. B. DeutEx ...

Graphical user interface (GUI) for HPLC-MS data analysis. Enables HPLC and MS data file processing and the visualization of the data. Used for data generated by LabSolutions data analysis software.

Bruker Corporation (Nasdaq: BRKR) announced today that it will unveil significant advancements in spatial biology at the 2025 Advances in Genome Biology and Technology (AGBT) General Meeting. Bruker ...

The National Institute on Alcohol Abuse and Alcoholism awarded more than $300,000 in exploratory funding to a team of researchers at USF to study the cellular and molecular changes underlying damage ...

2025 Non-GAAP EPS Guidance: $2.67 to $2.72, representing 11% to 13% growth. Bruker Corp (NASDAQ:BRKR) reported a strong Q4 2024 with a 14.6% year-over-year increase in revenues, reaching $979.6 ...

Good day, and welcome to the Bruker Corporation Fourth Quarter 2024 ... we could certainly do that. Yes. So timsTOF is doing better again. Obviously, we had some competitive dynamics there when ...

Bruker exceeded both EPS and revenue forecasts for Q4 2024. The company reported a 14.6% year-over-year increase in quarterly revenue. Stock price decreased by 0.77% despite the earnings beat ...

BILLERICA, Mass.--(BUSINESS WIRE)--$BRKR #BRKR--Bruker Corporation (Nasdaq: BRKR) today announced financial results for its fourth quarter and for the full year ended ...

Scientific instrument company Bruker (NASDAQ:BRKR). will be reporting results tomorrow before market hours. Here’s what investors should know. Bruker met analysts’ revenue expectations last ...